Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
38.15
-1.50 (-3.78%)
Jul 9, 2026, 2:36 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.93 billion as of July 9, 2026. Its market cap has increased by 37.23% in one year.
Market Cap
2.93B
Enterprise Value
3.45B
Revenue
973.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.15
Market Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.93B, a decrease of -44.27%. That is a compound annual growth rate of -3.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.93B | 55.71% |
| Dec 31, 2025 | 1.88B | -28.33% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.68B |
| Sagittarius Life Science | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.29B |
| Energenesis Biomedical CO.,LTD. | 3.23B |
| BioGend Therapeutics | 3.19B |
| Shine-On BioMedical | 3.19B |
| Apex Biotechnology | 3.02B |
| GlycoNex Incorporation | 2.93B |